{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:16:34Z","timestamp":1740633394139,"version":"3.38.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10067-025-07351-w","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T07:52:24Z","timestamp":1738223544000},"page":"1367-1375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease masquerading as rheumatoid arthritis-associated interstitial lung disease or overlapping with the same: a phenomenon driven by a probable genetic predisposition"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-729X","authenticated-orcid":false,"given":"Abraham","family":"Mohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiswarya","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob George","family":"Pulinilkunnathil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepu","family":"M.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"7351_CR1","unstructured":"Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R (2010) Extra-articular manifestations in rheumatoid arthritis. M\u00e6dica 5(4):286. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3152850\/"},{"issue":"3","key":"7351_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00002281-199805000-00007","volume":"10","author":"JD Reveille","year":"1998","unstructured":"Reveille JD (1998) The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 10(3):187\u2013200. https:\/\/doi.org\/10.1097\/00002281-199805000-00007","journal-title":"Curr Opin Rheumatol"},{"key":"7351_CR3","unstructured":"Mielants H. Extra-articular manifestations. https:\/\/pubmed.ncbi.nlm.nih.gov\/19822047\/"},{"issue":"2","key":"7351_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wu","year":"2021","unstructured":"Wu W, Guo L, Fu Y, Wang K, Zhang D, Xu W et al (2021) Interstitial lung disease in anti-MDA5 positive dermatomyositis. Clinic Rev Allerg Immunol 60(2):293\u2013304. https:\/\/doi.org\/10.1007\/s12016-020-08822-5","journal-title":"Clinic Rev Allerg Immunol"},{"issue":"1","key":"7351_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s42358-023-00318-y","volume":"63","author":"KR Bonfiglioli","year":"2023","unstructured":"Bonfiglioli KR, de Medeiros Ribeiro AC, Carnieletto AP, Pereira I, Domiciano DS, da Silva HC et al (2023) Extra-articular manifestations of rheumatoid arthritis remain a major challenge: data from a large, multi-centric cohort. Adv Rheumatol 63(1):34. https:\/\/doi.org\/10.1186\/s42358-023-00318-y","journal-title":"Adv Rheumatol"},{"issue":"6","key":"7351_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/pl00006853","volume":"19","author":"MA Cimmino","year":"2000","unstructured":"Cimmino MA, Salvarani C, Macchioni P et al (2000) Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 19(6):213\u2013217. https:\/\/doi.org\/10.1007\/pl00006853","journal-title":"Rheumatol Int"},{"key":"7351_CR7","doi-asserted-by":"publisher","unstructured":"Laria A, Lurati AM, Zizzo G et al (2022) Interstitial lung disease in rheumatoid arthritis: a practical review. Front Med (Lausanne) 9:837133. Published 2022 May 13. https:\/\/doi.org\/10.3389\/fmed.2022.837133","DOI":"10.3389\/fmed.2022.837133"},{"issue":"1","key":"7351_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/rheumato4010004","volume":"4","author":"S Bhandari","year":"2024","unstructured":"Bhandari S, Zickuhr L, Baral MR, Bhalla S, Jones H, Bucelli R et al (2024) A review of MDA-5 dermatomyositis and associated interstitial lung disease. Rheumato 4(1):33\u201348. https:\/\/doi.org\/10.3390\/rheumato4010004","journal-title":"Rheumato"},{"issue":"12","key":"7351_CR9","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3390\/jcm8122038","volume":"8","author":"E Bendstrup","year":"2019","unstructured":"Bendstrup E, M\u00f8ller J, Kronborg-White S, Prior TS, Hyldgaard C (2019) Interstitial lung disease in rheumatoid arthritis remains a challenge for clinicians. J Clin Med 8(12):2038. https:\/\/doi.org\/10.3390\/jcm8122038","journal-title":"J Clin Med"},{"issue":"12","key":"7351_CR10","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1007\/s11606-021-07131-7","volume":"36","author":"CB Kersey","year":"2021","unstructured":"Kersey CB, Oshinsky C, Wahl ER, Newman TA (2021) Anti-MDA5 Antibody-associated clinically amyopathic dermatomyositis: case report and literature review. J Gen Intern Med 36(12):3865. https:\/\/doi.org\/10.1007\/s11606-021-07131-7","journal-title":"J Gen Intern Med"},{"issue":"3","key":"7351_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10165-012-0663-4","volume":"23","author":"S Sato","year":"2013","unstructured":"Sato S, Kuwana M, Fujita T, Suzuki Y (2013) Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 23(3):496\u2013502. https:\/\/doi.org\/10.1007\/s10165-012-0663-4","journal-title":"Mod Rheumatol"},{"issue":"4","key":"7351_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","volume":"54","author":"P Gerami","year":"2006","unstructured":"Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD (2006) A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 54(4):597\u2013613. https:\/\/doi.org\/10.1016\/j.jaad.2005.10.041","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"7351_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/medicina59020363","volume":"59","author":"S Oka","year":"2023","unstructured":"Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Hashimoto A et al (2023) Antibodies against serum anti-melanoma differentiation-associated gene 5 in rheumatoid arthritis patients with chronic lung diseases. Medicina (Kaunas) 59(2):363. https:\/\/doi.org\/10.3390\/medicina59020363","journal-title":"Medicina (Kaunas)"},{"issue":"12","key":"7351_CR14","doi-asserted-by":"publisher","first-page":"773352","DOI":"10.3389\/fimmu.2021.773352.PMID:34745149;PMCID:PMC8564476","volume":"20","author":"A Nombel","year":"2021","unstructured":"Nombel A, Fabien N, Coutant F (2021) Dermatomyositis with Anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol 20(12):773352. https:\/\/doi.org\/10.3389\/fimmu.2021.773352.PMID:34745149;PMCID:PMC8564476","journal-title":"Front Immunol"},{"issue":"8","key":"7351_CR15","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/acr.21992","volume":"65","author":"JC Hall","year":"2013","unstructured":"Hall JC, Casciola-Rosen L, Samedy LA, Werner J, Owoyemi K, Danoff SK et al (2013) Anti-MDA5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res 65(8):1307. https:\/\/doi.org\/10.1002\/acr.21992","journal-title":"Arthritis Care Res"},{"issue":"8","key":"7351_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.14740\/jmc.v13i8.3965","volume":"13","author":"K Tavakolian","year":"2022","unstructured":"Tavakolian K, Odak M, Mararenko A, Ilagan J, Douedi S, Khan T et al (2022) Anti-MDA5 associated clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. J Med Cases 13(8):374. https:\/\/doi.org\/10.14740\/jmc.v13i8.3965","journal-title":"J Med Cases"},{"issue":"11","key":"7351_CR17","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1002\/art.34657","volume":"64","author":"T Gono","year":"2012","unstructured":"Gono T, Kawaguchi Y, Kuwana M, Sugiura T, Furuya T, Takagi K et al (2012) Brief report: association of HLA-DRB1*0101\/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. Arthritis Rheum 64(11):3736\u20133740. https:\/\/doi.org\/10.1002\/art.34657","journal-title":"Arthritis Rheum"},{"key":"7351_CR18","doi-asserted-by":"publisher","unstructured":"Nombel A, Fabien N, Coutant F (2021) Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol [Internet]. [cited 2024 Nov 9];12. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2021.773352\/full","DOI":"10.3389\/fimmu.2021.773352\/full"},{"key":"7351_CR19","doi-asserted-by":"publisher","unstructured":"Ruppel T, Forbes Kaprive J, Heydari-Kamjani M, Kesselman MM (2022) Anti-melanoma differentiation-associated gene 5 (anti-MDA5) dermatomyositis: a case presentation. Cureus 14(3):e23102. https:\/\/doi.org\/10.7759\/cureus.23102.doi:10.7759\/cureus.23102","DOI":"10.7759\/cureus.23102.doi:10.7759\/cureus.23102"},{"issue":"6","key":"7351_CR20","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00296-021-04819-1","volume":"41","author":"P Mehta","year":"2021","unstructured":"Mehta P, Machado PM, Gupta L (2021) Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry. Rheumatol Int 41(6):1021\u20131036","journal-title":"Rheumatol Int"},{"issue":"130","key":"7351_CR21","doi-asserted-by":"publisher","first-page":"102831","DOI":"10.1016\/j.jaut.2022.102831","volume":"1","author":"F Coutant","year":"2022","unstructured":"Coutant F, Bachet R, Pin JJ, Alonzo M, Miossec P (2022) Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production. J Autoimmun 1(130):102831. https:\/\/doi.org\/10.1016\/j.jaut.2022.102831","journal-title":"J Autoimmun"},{"issue":"7","key":"7351_CR22","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T et al (2009) RNA helicase encoded by melanoma differentiation\u2013associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum 60(7):2193\u20132200. https:\/\/doi.org\/10.1002\/art.24621","journal-title":"Arthritis Rheum"},{"key":"7351_CR23","doi-asserted-by":"publisher","unstructured":"Nombel A, Fabien N, Coutant F (2021) Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol [Internet]. [cited 2024 Nov 8];12. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2021.773352\/full","DOI":"10.3389\/fimmu.2021.773352\/full"},{"issue":"3","key":"7351_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3899\/jrheum.160682","volume":"44","author":"S Moghadam-Kia","year":"2017","unstructured":"Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R (2017) Antimelanoma differentiation-associated gene 5 antibody: expanding the clinical spectrum in North American patients with dermatomyositis. J Rheumatol 44(3):319\u2013325. https:\/\/doi.org\/10.3899\/jrheum.160682","journal-title":"J Rheumatol"},{"issue":"3","key":"7351_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.rdc.2017.04.003","volume":"43","author":"V van Drongelen","year":"2017","unstructured":"van Drongelen V, Holoshitz J (2017) HLA-disease associations in rheumatoid arthritis. Rheum Dis Clin North Am 43(3):363. https:\/\/doi.org\/10.1016\/j.rdc.2017.04.003","journal-title":"Rheum Dis Clin North Am"},{"key":"7351_CR26","unstructured":"Suarez-Almazor ME, Tao S, Moustarah F, Russell AS, Maksymowych W (1995) HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city-wide community-based study. J Rheumatol 22(11):2027\u201333. https:\/\/pubmed.ncbi.nlm.nih.gov\/8596139\/"},{"issue":"9","key":"7351_CR27","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3899\/jrheum.170165","volume":"44","author":"Z Chen","year":"2017","unstructured":"Chen Z, Wang Y, Kuwana M, Xu X, Hu W, Feng X et al (2017) HLA-DRB1 alleles as genetic risk factors for the development of anti-MDA5 antibodies in patients with dermatomyositis. J Rheumatol 44(9):1389\u20131393. https:\/\/doi.org\/10.3899\/jrheum.170165","journal-title":"J Rheumatol"},{"key":"7351_CR28","doi-asserted-by":"publisher","unstructured":"Selva-O\u2019Callaghan A, Romero-Bueno F, Trallero-Aragu\u00e1s E, Gil-Vila A, Ruiz-Rodr\u00edguez JC, S\u00e1nchez-Pernaute O et al (2021) Pharmacologic treatment of anti-MDA5 rapidly progressive interstitial lung disease. Curr Treatm Opt Rheumatol 7(4):319\u201333. https:\/\/doi.org\/10.1007\/s40674-021-00186-x","DOI":"10.1007\/s40674-021-00186-x"},{"issue":"1","key":"7351_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10238-024-01300-8","volume":"24","author":"S Hirsch","year":"2024","unstructured":"Hirsch S, P\u00f6hler GH, Seeliger B, Prasse A, Witte T, Thiele T (2024) Treatment strategies in MDA5-positive clinically amyopathic dermatomyositis: a single-center retrospective analysis. Clin Exp Med 24(1):37. https:\/\/doi.org\/10.1007\/s10238-024-01300-8","journal-title":"Clin Exp Med"},{"issue":"12","key":"7351_CR30","doi-asserted-by":"publisher","first-page":"103668","DOI":"10.1038\/s41584-023-01054-9","volume":"23","author":"F Luppi","year":"2024","unstructured":"Luppi F, Manfredi A, Faverio P, Franco G, Salvarani C, Bendstrup E et al (2024) Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: more questions than answers. Autoimmun Rev 23(12):103668. https:\/\/doi.org\/10.1038\/s41584-023-01054-9","journal-title":"Autoimmun Rev"},{"issue":"1","key":"7351_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/BOR.0000000000000979","volume":"36","author":"M Yasui","year":"2024","unstructured":"Yasui M, Iwamoto T, Furuta S (2024) New therapies in anti-MDA5 antibody-positive dermatomyositis. Curr Opin Rheumatol 36(1):61\u201368. https:\/\/doi.org\/10.1097\/BOR.0000000000000979","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"7351_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fmed.2019.00239","volume":"5","author":"Y Ning","year":"2019","unstructured":"Ning Y, Yang G, Sun Y, Chen S, Liu Y, Shi G (2019) Efficiency of therapeutic plasma-exchange in acute interstitial lung disease, associated with polymyositis\/Dermatomyositis resistant to glucocorticoids and immunosuppressive drugs: a retrospective study. Front Med 5(6):239. https:\/\/doi.org\/10.3389\/fmed.2019.00239","journal-title":"Front Med"},{"issue":"4","key":"7351_CR33","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A (2021) Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev 20(4):102776. https:\/\/doi.org\/10.1016\/j.autrev.2021.102776","journal-title":"Autoimmun Rev"},{"issue":"19","key":"7351_CR34","doi-asserted-by":"publisher","first-page":"14509","DOI":"10.1378\/chest.09-0444","volume":"24","author":"Y Kim","year":"2023","unstructured":"Kim Y, Yang HI, Kim KS (2023) Etiology and pathogenesis of rheumatoid arthritis-interstitial lung disease. Int J Mol Sci 24(19):14509. https:\/\/doi.org\/10.1378\/chest.09-0444","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7351_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1148\/radiol.2321030174","volume":"232","author":"N Tanaka","year":"2004","unstructured":"Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R et al (2004) Rheumatoid arthritis\u2013related lung diseases: CT findings. Radiology 232(1):81\u201391. https:\/\/doi.org\/10.1148\/radiol.2321030174","journal-title":"Radiology"},{"issue":"4","key":"7351_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40265-014-0190-z","volume":"74","author":"RW Hallowell","year":"2014","unstructured":"Hallowell RW, Horton MR (2014) Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced. Drugs 74(4):443\u2013450. https:\/\/doi.org\/10.1007\/s40265-014-0190-z","journal-title":"Drugs"},{"key":"7351_CR37","doi-asserted-by":"publisher","unstructured":"Liang M, Matteson EL, Abril A, Distler JH (2022) The role of antifibrotics in the treatment of rheumatoid arthritis\u2013associated interstitial lung disease. Ther Adv Musculoskelet Dis 14:1759720X221074457. https:\/\/doi.org\/10.1177\/1759720X221074457","DOI":"10.1177\/1759720X221074457"},{"key":"7351_CR38","doi-asserted-by":"crossref","unstructured":"Reveille JD (1998) MD.\u00a0The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 10(3): 187\u2013200. https:\/\/journals.lww.com\/co-rheumatology\/abstract\/1998\/05000\/the_genetic_contribution_to_the_pathogenesis_of.7.aspx","DOI":"10.1097\/00002281-199805000-00007"},{"key":"7351_CR39","doi-asserted-by":"publisher","unstructured":"\u201cJawaheer D, Thomson W, MacGregor AJ et al (1994) \"Homozygosity\" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 37(5):681\u2013686. https:\/\/doi.org\/10.1002\/art.1780370511","DOI":"10.1002\/art.1780370511"},{"issue":"5","key":"7351_CR40","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/cells9051127","volume":"9","author":"T Wysocki","year":"2020","unstructured":"Wysocki T, Olesi\u0144ska M, Paradowska-Gorycka A (2020) Current understanding of an emerging role of HLA-DRB1 gene in rheumatoid arthritis\u2013from research to clinical practice. Cells 9(5):1127. https:\/\/doi.org\/10.3390\/cells9051127","journal-title":"Cells"},{"issue":"5","key":"7351_CR41","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/art.20693","volume":"51","author":"C Turesson","year":"2004","unstructured":"Turesson C, Weyand CM, Matteson EL (2004) Genetics of rheumatoid arthritis: is there a pattern predicting extraarticular manifestations? Arthritis Rheum 51(5):853\u2013863. https:\/\/doi.org\/10.1002\/art.20693","journal-title":"Arthritis Rheum"},{"issue":"1","key":"7351_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3899\/jrheum.090303","volume":"37","author":"K Migita","year":"2010","unstructured":"Migita K, Nakamura T, Koga T, Eguchi K (2010) HLA-DRB1 alleles and rheumatoid arthritis-related pulmonary fibrosis. J Rheumatol 37(1):205\u2013207. https:\/\/doi.org\/10.3899\/jrheum.090303","journal-title":"J Rheumatol"},{"issue":"6","key":"7351_CR43","doi-asserted-by":"publisher","first-page":"R1386","DOI":"10.1186\/ar1837","volume":"7","author":"C Turesson","year":"2005","unstructured":"Turesson C, Schaid DJ, Weyand CM et al (2005) The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther 7(6):R1386\u2013R1393. https:\/\/doi.org\/10.1186\/ar1837","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"7351_CR44","doi-asserted-by":"publisher","first-page":"e002076","DOI":"10.1136\/bmjresp-2023-002076","volume":"10","author":"S Nayebirad","year":"2023","unstructured":"Nayebirad S, Mohamadi A, Yousefi-Koma H, Javadi M, Farahmand K, Atef-Yekta R et al (2023) Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis. BMJ Open Respir Res 10(1):e002076. https:\/\/doi.org\/10.1136\/bmjresp-2023-002076","journal-title":"BMJ Open Respir Res"},{"issue":"9","key":"7351_CR45","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Satoh T et al (2010) Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford) 49(9):1713\u20131719. https:\/\/doi.org\/10.1093\/rheumatology\/keq149","journal-title":"Rheumatology (Oxford)"},{"issue":"2023","key":"7351_CR46","doi-asserted-by":"publisher","first-page":"2988422","DOI":"10.1155\/2023\/2988422","volume":"4","author":"CH Liu","year":"2023","unstructured":"Liu CH, Kor CT, Hung MH, Hsiao KH, Cheng YH, Tien YC (2023) Differences in the clinical characteristics and 1-year mortality rates of patients with dermatomyositis with anti-Jo-1 and anti-MDA5 antibodies. J Immunol Res 4(2023):2988422. https:\/\/doi.org\/10.1155\/2023\/2988422","journal-title":"J Immunol Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07351-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07351-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07351-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:23:18Z","timestamp":1740558198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07351-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7351"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07351-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}